6-8
Oct
2026
CPHI Milan 2026
Fiera Milano, Italy
8S01

Zenovel

About Zenovel

Zenovel Pharma Services LLP is an emerging global consulting partner specializing in GxP compliance, Regulatory Affairs, and Quality Excellence for the pharmaceutical, biotechnology, and medical device industries.

We support clients with Clinical Monitoring, Sponsor Oversight, GCP and GMP Audits, Computer System Validation (CSV), Regulatory Strategy, Dossier Preparation, and Quality Consulting.

Combining deep industry expertise with a flexible global delivery model, we help organizations achieve inspection readiness, regulatory compliance, and operational excellence across every stage of the product lifecycle.

Meet us at

  • CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
  • Country/Region:
    India
  • Founded:
    2020
  • On CPHI since:
    2021
  • Certificates:
    1
  • Employees:
    25 - 49
Company types
Consultancy
Contract Service
Start-up
Primary activities
Biopharmaceutical
Clinical Research
Medical Devices
Other
Regulatory Affairs
Contact info

Products from Zenovel (3)

  • Clinical Lifecycle Management

    Product Clinical Lifecycle Management

    We offer a range of GCP services, from monitoring to audits. Providing comprehensive GCP compliance services for the pharmaceutical industry is one of our specialties.

    A.   Risk-Based Monitoring: 

    ✔ Risk-Based Monitoring for Bioequivalence/Bioavailability Studies (BE...
  • GMP Audit & Consulting Services

    Product GMP Audit & Consulting Services

    We aim to provide the most reliable and preferred service platform to pharmaceutical companies worldwide for R&D cycle, regulatory affairs, and GMP compliance with a higher benchmark of quality, integrity, and ethics.

    ...
  • Regulatory Support

    Product Regulatory Support

    Zenovel has a highly experienced team of experts who have a complete understanding of the complete requirements of Pharma Regulatory affairs throughout the drug life cycle. Our experts have experience in directly corresponding with Pharma regulatory authorities for various segments.
    ...